Navigation Links
Artery in Medical Technology

Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients

Pre-heparinization Limits Clot Retention and Decreases Residual Clot Volume SAN FRANCISCO, June 8 /PRNewswire/ -- MAQUET Cardiovascular LLC announced today that data presented at the annual meeting of the International Society for Minimally Invasive Cardiothoracic Surgery show that administ...

Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease

NATICK, Mass., May 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced the start of patient enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC(TM) Self-Expanding Nitinol Stent System for the treatment of iliac artery disea...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

NATICK, Mass. and BARCELONA, Spain, May 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial. The results found that percutaneous coronary ...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease

NATICK, Mass. and ORLANDO, Fla., March 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial. The results found that while the overall cost ...

Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease

-- Exploratory study shows clinical improvement in patients with pulmonary arterial hypertension (PAH) -- Current treatment options have limited benefit for this debilitating, rapidly progressive and incurable blood vessel disease -- Imatinib mesylate, available as Gleevec(R)...

SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease

One-Year Data Find Angioplasty and Stenting Safe and Effective in Patients for Whom Standard Therapy Has Been Open-Heart Surgery WASHINGTON, Sept. 1 /PRNewswire/ -- Data announced today from the landmark SYNTAX trial indicate that patients with very complex coronary artery disease can s...

FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)

BOSTON, March 3 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough cardiovascular molecular imaging agents for the Positron Emission Tomography (PET) market, announced positive Phase I safety results for CardioPET, the company's lead product. The trial was designed to evalu...

Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results

NATICK, Mass. and WASHINGTON, Oct. 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced positive three-year results from its CABERNET and BEACH carotid artery stenting clinical trials. The studies evaluated the effectiveness of stenting with embolic protecti...

Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease

ROCKVILLE, Md., Oct. 15 /PRNewswire-USNewswire/ -- Patients with mid-range coronary artery disease are more likely to get relief from painful angina and less likely to have repeat procedures if they get bypass surgery rather than balloon angioplasty with or without a stent, according to a new ...

Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis

HERCULES Trial Aims to Treat Renal Artery Obstructions and Lower Blood Pressure in Patients Not Responding to Medication ABBOTT PARK, Ill., Sept. 25 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced enrollment of the first patient in HERCULES (Herculink Elite Cobalt Chrom...

Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet Primary Endpoint

LONDON, March 19, 2007-AstraZeneca today announced that its collaboration partner AtheroGenics, Inc. (Nasdaq: AGIX) revealed first results from the ARISE (Aggressive Reduction of Inflammation Stops Events) phase III clinical outcomes trial which studied AGI-1067, an investigational anti-atheroscle...

Hospitalization Rates for Coronary Artery Disease Decline in the U.S.

EVANSTON, Ill., March 20, 2007 /PRNewswire/ -- Treatment of coronary artery disease (CAD) appears to be shifting away from the inpatient setting, according to a study published today in The American Journal of Cardiology. U.S. hospitalization rates for heart attacks (acute myocardial infarctions...

Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke

EXACT and CAPTURE 2 Findings Suggest Improved Outcomes in Carotid Artery Stenting ABBOTT PARK, Ill., March 26, 2007 /PRNewswire-FirstCall/ -- Positive 30-day results from two Abbott studies confirm that carotid stenting can be performed with positive results by physicians with a variety of backgro...

Cypher Sirolimus-eluting Coronary Stent Had Similar Results to Bypass Surgery in Long-Term Study of Patients With Multi-Vessel Coronary Artery Disease

NEW ORLEANS, March 26, 2007 /PRNewswire-FirstCall/ -- Three-year follow-up data presented today at the of Cardiology's 56th Annual Scientific Session (ACC.07) showed that the CYPHER(R) Sirolimus-eluting Coronary Stent had results comparable to coronary artery bypass grafting (CABG or bypass surger...

ACC Presentation Indicates Interleukin-1 Gene Variants Determine Increased Risk for Coronary Artery Disease from Oxidized Phospholipids

WALTHAM, Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Interleukin Genetics, Inc. (AMEX:ILI) and collaborators at the University of California San Diego today reported at the American College of Cardiology annual meeting that associations between coronary artery disease (CAD) and both oxidized phospholipi...

BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

WAKEFIELD, Mass.--(BUSINESS WIRE)--Jul 6, 2007 - BusinessWeek today published an article discussing the race by pharmaceutical and biotechnology companies to be first to bring to market an effective angiogenesis treatment for cardiovascular disease. While angiogenesis therapies are being pursued by...

BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

WAKEFIELD, Mass.--(BUSINESS WIRE)--Jul 10, 2007 - BusinessWeek published an article on July 6 discussing the race by pharmaceutical and biotechnology companies to be first to bring to market an effective angiogenesis treatment for cardiovascular disease. While angiogenesis therapies are being pursu...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... refine its European strategy for mipomersen. Isis and Genzyme completed enrollment in a Phase 3 study in heterozygous FH patients with coronary artery disease. Isis' partnered pipeline continues to mature as antisense drugs that Isis' satellite companies are developing advance in c...

2,500 Cases Completed With the Magnetic Irrigated Catheter

...nd markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

...rld. But while the efficacy of minimally invasive coiling has been proven many times over in the case of intracranial aneurysms (a bulge in the artery wall which can suddenly burst, leading to bleeding in the brain that may result in severe disability, or even death), less is known about the psychoso...

World's First Cardiac Adult Stem Cell Patient Receives Infusion

...asive cardiac catheterization procedure, which reaches the heart through an artery in the patient's leg. The 66-year-old, self-employed man continues to recov...and Mechanical Assist Device Program at Jewish Hospital, performed coronary artery bypass surgery on Jones on March 23. Jones suffered from congestive heart f...

Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results

...osis, between a vein graft and the aorta, the main artery in the human body, during coronary artery bypass grafting (CABG) procedures. "The ...ider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sew...

SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine

... their patients, as studied in this trial. BARI-2D specifically applies to those with carefully controlled diabetes, multi-vessel but stable coronary artery disease (CAD), and few heart disease symptoms. This trial does not answer the question of whether all patients with diabetes and multi-vessel CAD mig...

Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting

...d Transmyocardial Laser Revascularization for Diffuse Nongraftable Coronary artery Disease" can be located at: http://www.ismics.org/abstracts/2009/10.htm... to reduce angina and improve the quality of life in patients with coronary artery disease. For more information on the company and its products, please ...

Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013

...the number of endovascular procedures that treat lower extremity peripheral artery disease in Europe is being fueled by positive clinical trial results, incre...dovascular infrapopliteal procedures, which treat below-the-knee peripheral artery disease, are also growing rapidly," says Stephanie Labelle, Senior Analyst ...

Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent

...ed platinum chromium platform and are designed to provide interventional cardiologists improved performance in treating patients with complex coronary artery disease. The Company is anticipating CE Mark approval for both the TAXUS Element Stent and the PROMUS Element Stent Systems in the fourth quarter of ...

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

...In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have b... use of olmesartan medoxomil in patients with unilateral or bilateral renal artery stenosis, but similar results may be expected. Adverse Events ...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

...In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have b... use of olmesartan medoxomil in patients with unilateral or bilateral renal artery stenosis, but similar results may be expected. The prescribing inform...

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure

...aortic stenosis. Severe Obstructive Coronary artery Disease Patients, particularly those with severe obstructive coronary artery disease, may develop increased frequency, duration...ors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood u...

InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients

...ng stents. InspireMD intends to pursue applications of this technology both for bare metal and drug eluting stents in coronary, carotid and peripheral artery procedures. For further information visit http://www.inspire-md.com Contact: Jonina Ohayon Marketing Director Tel +972-52-57911...

New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

...008%20web-161229A.pdf , Accessed August 13, 2008. (6) WebMD Medical Reference in Collaboration with the Cleveland Clinic. Heart Disease: Coronary artery Disease. http://www.webmd.com/heart-disease/guide/heart-disease-coronary-artery-disease . Accessed August 13, 2008. (Logo: http://www.newsco...

AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product

...ai, et al. A Systematic Review and Meta-Analysis on the Hazards of Discontinuing Or Not Adhering to Aspirin Among 50 279 Patients at Risk for Coronary artery Disease. European Heart Journal . 2006;27:2667-2674. CAPRIE Steering Committee. A Randomised, Blinded, Trial of Clopidogrel Versus Aspirin in...

Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study

...s committed to advancing the science of peripheral artery disease treatment with a goal of making plaque exc...atment of moderate to heavily calcified peripheral artery lesions. For information about the DEFINITIVE LE s..._new"> clinical@ev3.net . About Peripheral artery Disease Peripheral arterial disease (PAD) occu...

Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting

...g addiction/overdose; nerve palsy (facial, oculomotor); cardiomyopathy, myocardial infarction, angina, pericardial effusion, retinal ischemia, retinal artery or vein thrombosis, blindness, decreased visual acuity, optic neuritis, transient ischemic attack, supraventricular arrhythmias, loss of consciousness...

Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients

...g addiction/overdose; nerve palsy (facial, oculomotor); cardiomyopathy, myocardial infarction, angina, pericardial effusion, retinal ischemia, retinal artery or vein thrombosis, blindness, decreased visual acuity, optic neuritis, transient ischemic attack, supraventricular arrhythmias, loss of consciousness...

Schering-Plough Announces Results of the Early ACS Trial

...nsure a minimum 18-hour infusion post-PCI). In patients undergoing coronary artery bypass graft (CABG) surgery, the infusion continued until 2 hours preoperat... The majority of excess major bleeding events were localized at the femoral artery access site. Oropharyngeal, genitourinary, gastrointestinal and retroperito...

Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years

...) with either one or two de novo native coronary artery lesions. Patients from Europe, India and New Zeala...ut XIENCE V XIENCE V is used to treat coronary artery disease by propping open a narrowed or blocked artery and releasing the drug, everolimus, in a controlle...

AHRQ-Funded Study Finds Lower Risk of Death and Heart Attack in Patients With Drug-Coated Stent Implants Compared to Those With Bare Metal Stents

...rchers found no significant differences in the percentages of drug-eluting and bare metal stent patients who required a repeat angioplasty or coronary artery bypass graft surgery (roughly 23 percent) and in the percentages of patients who suffered strokes or major bleeding (about 3 percent and 3.5 percent, ...

DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium

...Management: Recent data reveals superior outcomes in the areas of CKD and mortality, anemia, incident patient management and phosphorus and coronary artery calcification. DaVita researchers note a nearly 50 percent drop in one-year mortality in Detroit area, DaVita-managed CKD clinics compared to Renal N...

Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial

...t bioabsorbable devices are the future of coronary artery disease treatment." Results from the first ...olimus eluting stent successfully treated coronary artery disease, and that at two years, the treated vessel...event that resulted in re-treatment of the treated artery lesion (ischemia-driven target lesion revasculariz...
Other Tags
(Date:7/11/2014)... Wildlife Conservation Society shows that no-take zones in ... such as lobster, conch, and fish recover from ... areas. , The reporttitled "Review of the Benefits ... literature from no-take areas around the world. The ... recognized expert in marine protected areas and fisheries ...
(Date:7/11/2014)... eastern New South Wales, Australia when NASA,s Aqua satellite ... on July 11 (12:35 p.m. local time/11:35 p.m. EDT ... South Wales (NSW), the Moderate Resolution Imaging Spectroradiometer (MODIS) ... and spotted smoke (light brown) from various fires. Actively ... in red. , The New South Wales, Australia Government ...
(Date:7/11/2014)... Research awarded Michael F. Holick, PhD, MD, of Boston ... V. Avioli Award. Holick, a professor of medicine, physiology ... the understanding of vitamin D and its role in ... of the American Society for Bone and Mineral Research ... research. It is named for ASBMR,s first president and ...
Breaking Biology News(10 mins):Belize's lobster, conch, and fish populations rebuild in no-take zones 2BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award 2
(Date:7/13/2014)... 13, 2014 The North American water storage ... 2013 to $5,450 million by 2018, at a CAGR of ... is expanding at a rapid pace in North America. The ... laws on water & wastewater storage and collection, and the ... market is expanding at a healthy rate in Canada, and ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 The ... Copper, Molybdenum, Iron), Form (Chelated & Non Chelated), ... Geography - Global Trends and Forecast to 2018” ... with an analysis and forecasting of the global ... identifies the driving and restraining factors for the ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Fuel additives ... as gasoline, diesel, jet fuel, kerosene, and so on, ... also responsible for reducing the corrosion effects caused by ... when added to any fuel, provide economies of scale ... these escalate the overall cost of the fuel products. ...
(Date:7/13/2014)... 2014 MarketsandMarkets recently conducted a ... 3D Scanning; 3D rendering; Layout and Animation; Image ... - 2018)”, which analyzes and studies the major ... Western Europe, Eastern Europe, Middle East and Africa, ... the competitive landscape of the 3D imaging market, ...
(Date:7/13/2014)... Serena Gordon HealthDay ... A new type of sensor for people with diabetes ... using saliva instead of blood, researchers report. Scientists at ... tested it using artificial saliva. It uses light, metal and ... sugar. "Everybody knows that diabetics have to prick their ...
Breaking Medicine News(10 mins):Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 2Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 4Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3
Other Contents